Thursday 10/1 Insider Buying Report: XENE
Published . Updated .
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at one noteworthy recent insider buy. At Xenon Pharmaceuticals, there was insider buying on Wednesday, by Chief Financial
Directly affected
- XENE Xenon Pharmaceuticals
Named in this report.
Indirectly affected
- JPM JPMorgan Chase
Bank profits move with lending and interest rates
- BAC Bank of America
Bank profits move with lending and interest rates
- WFC Wells Fargo
Bank profits move with lending and interest rates
- C Citigroup
Bank profits move with lending and interest rates
- GS Goldman Sachs
Bank profits move with lending and interest rates
- MS Morgan Stanley
Bank profits move with lending and interest rates
- XLF Financial Select Sector SPDR
A fund of financial companies
- KBE SPDR S&P Bank
A fund of bank stocks
- KRE SPDR S&P Regional Banking
Regional banks are sensitive to deposits and rates
- COPY TWEEDY BROWNE INSIDER VALUE ETF
GA selected COPY as a RELATED security because its canonical security name directly matches this event's themes: insider. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at one noteworthy recent insider buy. At Xenon Pharmaceuticals, there was insider bu…
Source: Nasdaq Markets
Xenon Pharmaceuticals (XENE) since this story, compared with the market
Since the first closing price after “Thursday 10/1 Insider Buying Report: XENE,” Xenon Pharmaceuticals (XENE) is -7.76%. The S&P 500 fund (SPY) is -0.40% over the same days, a -7.37% difference versus the market.
Who is named in “Thursday 10/1 Insider Buying Report: XENE”
Companies tied to this story
- XENE Xenon Pharmaceuticals
In “Thursday 10/1 Insider Buying Report: XENE,” Xenon Pharmaceuticals (XENE) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names XENON PHARMACEUTICALS INC in the summary; GA resolved that company to XENE
- COPY Tweedy Browne Insider Value Etf
In “Thursday 10/1 Insider Buying Report: XENE,” Tweedy Browne Insider Value Etf (COPY) is linked, with no stored direction, medium confidence. Reason on file: GA selected COPY as a RELATED security because its canonical security name directly matches this event's themes: insider. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Thursday 10/1 Insider Buying Report: XENE” reaches Xenon Pharmaceuticals (XENE)
“Thursday 10/1 Insider Buying Report: XENE” (1 Oct 2026) reaches Xenon Pharmaceuticals (XENE) through this story.
The link for Xenon Pharmaceuticals (XENE) is this: The reported development directly names XENON PHARMACEUTICALS INC in the summary; GA resolved that company to XENE
Tweedy Browne Insider Value Etf (COPY) is here too. Its reason reads: GA selected COPY as a RELATED security because its canonical security name directly matches this event's themes: insider. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Xenon Pharmaceuticals (XENE), and the dates in the story
COPY traded between 15.16 and 15.72 across 20 sessions. The latest close on file is 15.54. XENE traded between 33.41 and 59.35 across 15 sessions. The latest close on file is 35.05.
A simple score for Xenon Pharmaceuticals (XENE)
21 out of 100
“Thursday 10/1 Insider Buying Report: XENE” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.